Transcatheter closure of patent ductus arteriosus in pediatric patients

Larry A. Latson, Philip J. Hofschire, John Dale Kugler, John P. Cheatham, Carl Herbert Gumbiner, David Alan Danford

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

A "double disk" occlusion device (Rashkind PDA occluder system) has been designed to allow transcatheter closure of patent ductus arteriosus (PDA). During a 3-year period, we examined 37 infants and children (not premature neonates) with PDA as their only significant cardiovascular defect. Seventy-eight percent of these patients were considered potential candidates for the use of the PDA occlusion device, and it was successfully placed in all but 2 of 27 patients who underwent cardiac catheterization (PDA too small in one and too large in one). Only one of the remaining 25 patients had a significant residual shunt after placement of the device, which therefore was removed in the catheterization laboratory before surgical ligation of the PDA. There was no clinical evidence of a residual PDA in any patient. The duration of hospitalization was less than 24 hours for each of the last 20 procedures. Echocardiography demonstrated return to normal chamber dimensions in all patients, but a tiny, clinically undetectable residual leak around the device was found in three patients by Doppler evaluation. The transcatheter procedure was preferred over surgery by more than 90% of families and can be completed with a much shorter hospitalization than surgical ligation. We conclude that transcatheter closure of patent ductus arteriosus is feasible in the majority of children with PDA.

Original languageEnglish (US)
Pages (from-to)549-553
Number of pages5
JournalThe Journal of Pediatrics
Volume115
Issue number4
DOIs
StatePublished - Oct 1989

Fingerprint

Patent Ductus Arteriosus
Pediatrics
Equipment and Supplies
Ligation
Hospitalization
Cardiac Catheterization
Catheterization
Echocardiography
Newborn Infant

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Transcatheter closure of patent ductus arteriosus in pediatric patients. / Latson, Larry A.; Hofschire, Philip J.; Kugler, John Dale; Cheatham, John P.; Gumbiner, Carl Herbert; Danford, David Alan.

In: The Journal of Pediatrics, Vol. 115, No. 4, 10.1989, p. 549-553.

Research output: Contribution to journalArticle

@article{c7ef266f03c948cd8fcc2835ba309016,
title = "Transcatheter closure of patent ductus arteriosus in pediatric patients",
abstract = "A {"}double disk{"} occlusion device (Rashkind PDA occluder system) has been designed to allow transcatheter closure of patent ductus arteriosus (PDA). During a 3-year period, we examined 37 infants and children (not premature neonates) with PDA as their only significant cardiovascular defect. Seventy-eight percent of these patients were considered potential candidates for the use of the PDA occlusion device, and it was successfully placed in all but 2 of 27 patients who underwent cardiac catheterization (PDA too small in one and too large in one). Only one of the remaining 25 patients had a significant residual shunt after placement of the device, which therefore was removed in the catheterization laboratory before surgical ligation of the PDA. There was no clinical evidence of a residual PDA in any patient. The duration of hospitalization was less than 24 hours for each of the last 20 procedures. Echocardiography demonstrated return to normal chamber dimensions in all patients, but a tiny, clinically undetectable residual leak around the device was found in three patients by Doppler evaluation. The transcatheter procedure was preferred over surgery by more than 90{\%} of families and can be completed with a much shorter hospitalization than surgical ligation. We conclude that transcatheter closure of patent ductus arteriosus is feasible in the majority of children with PDA.",
author = "Latson, {Larry A.} and Hofschire, {Philip J.} and Kugler, {John Dale} and Cheatham, {John P.} and Gumbiner, {Carl Herbert} and Danford, {David Alan}",
year = "1989",
month = "10",
doi = "10.1016/S0022-3476(89)80279-3",
language = "English (US)",
volume = "115",
pages = "549--553",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Transcatheter closure of patent ductus arteriosus in pediatric patients

AU - Latson, Larry A.

AU - Hofschire, Philip J.

AU - Kugler, John Dale

AU - Cheatham, John P.

AU - Gumbiner, Carl Herbert

AU - Danford, David Alan

PY - 1989/10

Y1 - 1989/10

N2 - A "double disk" occlusion device (Rashkind PDA occluder system) has been designed to allow transcatheter closure of patent ductus arteriosus (PDA). During a 3-year period, we examined 37 infants and children (not premature neonates) with PDA as their only significant cardiovascular defect. Seventy-eight percent of these patients were considered potential candidates for the use of the PDA occlusion device, and it was successfully placed in all but 2 of 27 patients who underwent cardiac catheterization (PDA too small in one and too large in one). Only one of the remaining 25 patients had a significant residual shunt after placement of the device, which therefore was removed in the catheterization laboratory before surgical ligation of the PDA. There was no clinical evidence of a residual PDA in any patient. The duration of hospitalization was less than 24 hours for each of the last 20 procedures. Echocardiography demonstrated return to normal chamber dimensions in all patients, but a tiny, clinically undetectable residual leak around the device was found in three patients by Doppler evaluation. The transcatheter procedure was preferred over surgery by more than 90% of families and can be completed with a much shorter hospitalization than surgical ligation. We conclude that transcatheter closure of patent ductus arteriosus is feasible in the majority of children with PDA.

AB - A "double disk" occlusion device (Rashkind PDA occluder system) has been designed to allow transcatheter closure of patent ductus arteriosus (PDA). During a 3-year period, we examined 37 infants and children (not premature neonates) with PDA as their only significant cardiovascular defect. Seventy-eight percent of these patients were considered potential candidates for the use of the PDA occlusion device, and it was successfully placed in all but 2 of 27 patients who underwent cardiac catheterization (PDA too small in one and too large in one). Only one of the remaining 25 patients had a significant residual shunt after placement of the device, which therefore was removed in the catheterization laboratory before surgical ligation of the PDA. There was no clinical evidence of a residual PDA in any patient. The duration of hospitalization was less than 24 hours for each of the last 20 procedures. Echocardiography demonstrated return to normal chamber dimensions in all patients, but a tiny, clinically undetectable residual leak around the device was found in three patients by Doppler evaluation. The transcatheter procedure was preferred over surgery by more than 90% of families and can be completed with a much shorter hospitalization than surgical ligation. We conclude that transcatheter closure of patent ductus arteriosus is feasible in the majority of children with PDA.

UR - http://www.scopus.com/inward/record.url?scp=0024457780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024457780&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(89)80279-3

DO - 10.1016/S0022-3476(89)80279-3

M3 - Article

C2 - 2795344

AN - SCOPUS:0024457780

VL - 115

SP - 549

EP - 553

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 4

ER -